Teva CEO Richard Francis on Tariffs, Generics, and Business Strategy

Impact of Tariffs on Teva Pharmaceuticals

• ⚠️ Teva Pharmaceuticals is navigating uncertainty regarding new tariffs between the US and EU, particularly concerning their impact on pharmaceuticals.
• 💡 CEO Richard Francis highlighted that Teva has limited exposure to China and India, and their major US product is manufactured domestically in Florida, providing a strong supply chain position.
• ❓ Clarity is needed on whether generics are included in the tariffs, as this detail will significantly affect the market.
• 🤝 Teva has been working with the administration on understanding the complexities of the pharmaceutical market and has developed mitigation plans for potential tariff impacts.

Pricing Strategies for Innovative vs. Generic Drugs

• 🚫 For the innovative business, Teva cannot increase prices due to the system's structure, and tariffs are not directly relevant as key products are US-made.
• ⚖️ In the generics market, price increases are possible only with new contracts and depend heavily on the competitive environment and competitor actions.
• 💬 Teva is a major supplier in the US, and the administration is aware of the potential impact on medicine supply, showing sympathy towards ensuring good supply.

Most Favored Nation (MFN) Pricing Considerations

• 🌟 Teva is in a unique position regarding MFN pricing due to its young and growing innovative portfolio, which is primarily sold in the US.
• ⏳ This provides Teva with time to strategize on product launches and pricing, as their innovative business does not yet have a broad global footprint.
• 📊 The net price differential between the US and Europe for many drugs is not as significant as perceived, suggesting a need to wait and see how MFN plays out.

Teva's Active Ingredient Business Spin-off

• 🚀 Teva is in active discussions to sell its active ingredient business (API) and expects an announcement by the end of Q3.
• ✅ The primary goal of this divestiture is to create long-term sustainable shareholder value and ensure the company's future.
• 🗣️ Francis indicated that the process is ongoing, and they are taking time to ensure the best outcome for shareholders.